Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaNutra España is the Spanish subsidiary of the Italian pharmaceutical group PharmaNutra S.p.A., specializing in the development and commercialization of innovative nutritional supplements and medical devices. The company is best known for its proprietary Sucrosomial Technology, which enhances the absorption and tolerability of minerals like iron, magnesium, and zinc. Its flagship product line, SiderAL, addresses iron deficiency and anemia with high bioavailability and minimal side effects. Beyond iron, the company offers solutions for bone health, joint care, and sports recovery, leveraging its unique delivery systems to improve patient outcomes. PharmaNutra España operates as a direct commercial hub to expand the group's presence in the Iberian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmanutra España.